These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25327099)

  • 41. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
    Porter DW; Kerr BD; Flatt PR; Holscher C; Gault VA
    Diabetes Obes Metab; 2010 Oct; 12(10):891-9. PubMed ID: 20920042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
    Lee WC; Conner C; Hammer M
    Curr Med Res Opin; 2011 May; 27(5):897-906. PubMed ID: 21348806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Basal insulin and liraglutide combined in a pen].
    Rausch R
    Med Monatsschr Pharm; 2015 Apr; 38(4):154-6. PubMed ID: 26364391
    [No Abstract]   [Full Text] [Related]  

  • 44. A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs.
    Funch D; Gydesen H; Tornøe K; Major-Pedersen A; Chan KA
    Diabetes Obes Metab; 2014 Mar; 16(3):273-5. PubMed ID: 24199745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitus.
    Marino AB; Cole SW; Nuzum DS
    Am J Health Syst Pharm; 2014 Feb; 71(3):223-6. PubMed ID: 24429016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GLP-1 receptor agonist-induced polyarthritis: a case report.
    Ambrosio ML; Monami M; Sati L; Marchionni N; Di Bari M; Mannucci E
    Acta Diabetol; 2014 Aug; 51(4):673-4. PubMed ID: 24158775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats.
    Gaballah HH; Zakaria SS; Mwafy SE; Tahoon NM; Ebeid AM
    Biomed Pharmacother; 2017 Aug; 92():331-339. PubMed ID: 28554128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dulaglutide and liraglutide compared].
    Bruhn C
    Med Monatsschr Pharm; 2015 May; 38(5):198-9. PubMed ID: 26364414
    [No Abstract]   [Full Text] [Related]  

  • 49. Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.
    Courrèges JP; Vilsbøll T; Zdravkovic M; Le-Thi T; Krarup T; Schmitz O; Verhoeven R; Bugáñová I; Madsbad S
    Diabet Med; 2008 Sep; 25(9):1129-31. PubMed ID: 19183322
    [No Abstract]   [Full Text] [Related]  

  • 50. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.
    Steinberg WM; Nauck MA; Zinman B; Daniels GH; Bergenstal RM; Mann JF; Steen Ravn L; Moses AC; Stockner M; Baeres FM; Marso SP; Buse JB;
    Pancreas; 2014 Nov; 43(8):1223-31. PubMed ID: 25275271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
    Hussar DA; Kaczinski J
    J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
    [No Abstract]   [Full Text] [Related]  

  • 52. Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes.
    Nagai Y; Hashimoto E; Oikawa R; Asai S; Terashima Y; Nakamura Y; Sasaki Y; Tsukiyama H; Fukuda H; Ohshige T; Kato H; Ohta A; Tanaka Y
    Diabetes Obes Metab; 2014 Jun; 16(6):573-6. PubMed ID: 24320758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.
    Steinberg WM; Buse JB; Ghorbani MLM; Ørsted DD; Nauck MA; ;
    Diabetes Care; 2017 Jul; 40(7):966-972. PubMed ID: 28476871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early onset of acute pancreatitis in a patient on low-dose liraglutide.
    Chua MWJ; Ng YK
    Diabetes Metab Syndr; 2021; 15(3):753-755. PubMed ID: 33823330
    [No Abstract]   [Full Text] [Related]  

  • 55. Is there a link between liraglutide and pancreatitis? A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials.
    Jensen TM; Saha K; Steinberg WM
    Diabetes Care; 2015 Jun; 38(6):1058-66. PubMed ID: 25504028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.
    Dubois-Laforgue D; Boutboul D; Lévy DJ; Joly D; Timsit J
    Diabetes Res Clin Pract; 2014 Mar; 103(3):e53-5. PubMed ID: 24447807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.
    Nyborg NC; Mølck AM; Madsen LW; Knudsen LB
    Diabetes; 2012 May; 61(5):1243-9. PubMed ID: 22338093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An accidental liraglutide overdose: case report.
    Elmehdawi RR; Elbarsha AM
    Libyan J Med; 2014; 9(1):23055. PubMed ID: 24461534
    [No Abstract]   [Full Text] [Related]  

  • 59. [A 45-fold liraglutide overdose did not cause hypoglycaemia].
    Madsen LR; Christiansen JJ
    Ugeskr Laeger; 2015 Jan; 177(5):V11140595. PubMed ID: 25650514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Case of Sitagliptin-Induced Mild Acute Pancreatitis.
    Kocak MZ; Aktas G; Erkus E; Duman TT; Atak BM; Sahin D; Savli H
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):334. PubMed ID: 29615184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.